Steward Partners Investment Advisory LLC lifted its stake in The Allstate Co. (NYSE:ALL – Free Report) by 1.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 111,472 shares of the insurance provider’s stock after purchasing an additional 1,079 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Allstate were worth $21,491,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Chicago Partners Investment Group LLC lifted its stake in shares of Allstate by 1.3% in the third quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after purchasing an additional 59 shares during the period. Apella Capital LLC lifted its stake in shares of Allstate by 1.9% in the fourth quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider’s stock valued at $623,000 after purchasing an additional 60 shares during the period. Avior Wealth Management LLC lifted its stake in shares of Allstate by 4.9% in the third quarter. Avior Wealth Management LLC now owns 1,329 shares of the insurance provider’s stock valued at $252,000 after purchasing an additional 62 shares during the period. Perigon Wealth Management LLC lifted its stake in shares of Allstate by 2.1% in the fourth quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider’s stock valued at $571,000 after purchasing an additional 62 shares during the period. Finally, Mather Group LLC. lifted its stake in shares of Allstate by 1.7% in the fourth quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider’s stock valued at $697,000 after purchasing an additional 62 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.
Allstate Price Performance
Allstate stock opened at $201.87 on Tuesday. The Allstate Co. has a 1 year low of $153.87 and a 1 year high of $209.88. The firm has a 50 day moving average price of $190.43 and a 200 day moving average price of $191.27. The company has a market cap of $53.50 billion, a price-to-earnings ratio of 11.88, a PEG ratio of 1.01 and a beta of 0.52. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36.
Allstate announced that its board has initiated a stock repurchase program on Wednesday, February 26th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the insurance provider to purchase up to 3% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.
Allstate Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 10th will be issued a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 1.98%. This is an increase from Allstate’s previous quarterly dividend of $0.92. The ex-dividend date of this dividend is Monday, March 10th. Allstate’s payout ratio is presently 23.54%.
Insider Activity at Allstate
In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.80% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on ALL shares. Morgan Stanley lifted their target price on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. The Goldman Sachs Group lifted their target price on shares of Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. Barclays cut their target price on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research report on Monday, January 6th. Argus upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research report on Monday. Finally, Wells Fargo & Company lifted their target price on shares of Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 14th. One analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $217.94.
View Our Latest Stock Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- How to Invest in the FAANG Stocks
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Profitably Trade Stocks at 52-Week Highs
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to Invest in Blue Chip Stocks
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.